BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

760254

544644

CORONA

img img img img
No Data Available

Corona Remedies Ltd performance

Today’s low

Today’s high

₹ 1380.10 ₹ 1466.50
₹ 1440.70

52 week low

52 week high

₹ 1380.10 ₹ 1497.80
₹ 1440.70

Open Price

₹ 1414.00

Prev. Close

₹ 1438.40

Volume (Shares)

2610715.00

Total traded value

₹ 37612.57

Upper Circuit

₹ 1726.00

Lower Circuit

₹ 1150.80

info

Corona Remedies Ltd Share Price Update

As of the latest trading session, Corona Remedies Ltd share price is currently at ₹ 1440.9, which is up by ₹ 2.50 from its previous closing. Today, the stock has fluctuated between ₹ 1380.10 and ₹ 1466.50. Over the past year, Corona Remedies Ltd has achieved a return of [-] %. In the last month alone, the return has been [-] %. Read More...

Corona Remedies Ltd fundamentals


  • Market cap (Cr)

    8,811.30

  • P/E Ratio (TTM)

    58.97

  • Beta

    0.00

  • Book Value / share

    99.03

  • Return on equity

    27.45%

  • EPS (TTM)

    24.46

  • Dividend yield

    0.51%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    8,843.70

  • P/E Ratio (TTM)

    58.97

  • Beta

    0.00

  • Book Value / share

    99.03

  • Return on equity

    27.45%

  • EPS (TTM)

    24.46

  • Dividend yield

    0.51%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Corona Remedies Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Book Value / Share 99.14
ROE % 27.50
ROCE % 29.82
Total Debt to Total Equity 0.23
EBITDA Margin 20.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 78.55
ROE % 20.36
ROCE % 23.46
Total Debt to Total Equity 0.21
EBITDA Margin 15.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 66.80
ROE % 20.79
ROCE % 24.94
Total Debt to Total Equity 0.07
EBITDA Margin 15.30
Particulars MAR 2025 (Values in Cr)
Book Value / Share 99.04
ROE % 27.45
ROCE % 29.78
Total Debt to Total Equity 0.23
EBITDA Margin 20.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 78.51
ROE % 20.38
ROCE % 23.47
Total Debt to Total Equity 0.21
EBITDA Margin 15.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 66.70
ROE % 23.24
ROCE % 27.29
Total Debt to Total Equity 0.08
EBITDA Margin 15.27
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.86
ROE % -0.18
ROCE % 0.95
Total Debt to Total Equity 0.13
EBITDA Margin 3.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 727.91
ROE % 23.09
ROCE % 25.14
Total Debt to Total Equity 0.16
EBITDA Margin 19.15
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 69.27
Total Assets 929.86
Total Liabilities 929.86
Total Equity 606.34
Share Outstanding 61160088
Price to Book Ratio 0.00
Return on Assets (%) 16.07
Return on Capital (%) 22.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.90
Total Assets 830.57
Total Liabilities 830.57
Total Equity 480.40
Share Outstanding 61160088
Price to Book Ratio 0.00
Return on Assets (%) 10.89
Return on Capital (%) 14.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 76.69
Total Assets 595.02
Total Liabilities 595.02
Total Equity 408.52
Share Outstanding 61160088
Price to Book Ratio 0.00
Return on Assets (%) 14.27
Return on Capital (%) 20.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 69.27
Total Assets 929.24
Total Liabilities 929.24
Total Equity 605.72
Share Outstanding 61160088
Price to Book Ratio 0.00
Return on Assets (%) 16.03
Return on Capital (%) 22.3
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.90
Total Assets 830.34
Total Liabilities 830.34
Total Equity 480.17
Share Outstanding 61160088
Price to Book Ratio 0.00
Return on Assets (%) 10.89
Return on Capital (%) 14.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 76.69
Total Assets 594.79
Total Liabilities 594.79
Total Equity 408.29
Share Outstanding 61160088
Price to Book Ratio 0.00
Return on Assets (%) 14.24
Return on Capital (%) 20.63
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 100.97
Total Assets 511.36
Total Liabilities 511.36
Total Equity 320.90
Share Outstanding 51051000
Price to Book Ratio 0.00
Return on Assets (%) -0.07
Return on Capital (%) -0.11
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 39.55
Total Assets 396.31
Total Liabilities 396.31
Total Equity 269.15
Share Outstanding 4641000
Price to Book Ratio 0.00
Return on Assets (%) 14.98
Return on Capital (%) 19.01
Particulars MAR 2025 (Values in Cr)
Net Income 198.53
Cash from Operations 233.77
Cash from Investing -83.84
Cash from Financing -106.58
Net change in Cash 0.06
Free Cash Flow 325.41
Particulars MAR 2024 (Values in Cr)
Net Income 118.48
Cash from Operations 174.66
Cash from Investing -266.64
Cash from Financing 98.54
Net change in Cash -11.34
Free Cash Flow 461.00
Particulars MAR 2023 (Values in Cr)
Net Income 110.88
Cash from Operations 128.52
Cash from Investing -50.24
Cash from Financing -44.74
Net change in Cash 7.70
Free Cash Flow 223.27
Particulars MAR 2025 (Values in Cr)
Net Income 198.14
Cash from Operations 233.77
Cash from Investing -83.83
Cash from Financing -106.58
Net change in Cash 0.06
Free Cash Flow 325.42
Particulars MAR 2024 (Values in Cr)
Net Income 118.47
Cash from Operations 174.66
Cash from Investing -266.64
Cash from Financing 98.54
Net change in Cash -11.34
Free Cash Flow 461.00
Particulars MAR 2023 (Values in Cr)
Net Income 110.66
Cash from Operations 128.52
Cash from Investing -50.24
Cash from Financing -44.74
Net change in Cash 7.70
Free Cash Flow 223.28
Particulars MAR 2022 (Values in Cr)
Net Income -0.79
Cash from Operations 99.20
Cash from Investing -65.77
Cash from Financing -29.85
Net change in Cash 2.03
Free Cash Flow 133.20
Particulars MAR 2020 (Values in Cr)
Net Income 78.34
Cash from Operations 60.19
Cash from Investing -50.24
Cash from Financing 32.40
Net change in Cash 22.92
Free Cash Flow 60.19
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 29.09 14.26 1.51 222.93 25.97 / 64.99
BLISS GVS PHARMA LTD 142.75 13.78 1.33 1510.14 105.05 / 190.65
CIPLA LTD 1507.25 22.38 3.69 121751.32 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 351.15 9.23 2.64 1033.47 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 29.09 23.65 4.05 222.93 25.97 / 64.99
AMRUTAJAN HEALTH LTD 671.80 34.26 5.67 1942.22 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9124.55 98.68 28.54 22811.38 6301.00 / 10653.05
BLISS GVS PHARMA LTD 142.75 19.26 1.36 1510.14 105.05 / 190.65

Corona Remedies Ltd shareholding pattern

Holding

26.32%
68.99%
1.03%
3.64%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Corona Remedies Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1440.70 0.15 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 1438.40
  • 26 Days 1438.40
  • 10 Days 1438.40
  • 50 Days 1438.40
  • 12 Days 1438.40
  • 100 Days 1438.40
  • 20 Days 1438.40
  • 200 Days 1438.40
1449.73 PIVOT

First Support

1401.67

First Resistance

1486.47

Second Support

1364.93

Second Resistance

1534.53

Third Support

1316.87

Third Resistance

1571.27

RSI

0.00

ADX

0.00

MACD

0.00

Williams % R

-70.05

Commodity Channel Index (CCI)

0.00

Date

2025-12-15

Week

4297863.00

Same Day

4297863.00

Month

4297863.00

1 Year

0.0

3 Year

0.0

Over 1 Month

0.00%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Corona Remedies Ltd Corporate Actions

Corona Remedies Ltd Share Price

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli. Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'. A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024.

The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat). The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas.

In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005. The production of first manufacturing plant was commissioned at Solan, Himachal Pradesh in 2007. The Company launched Gynaecology division in 2008; further launched Cardioloy division in 2013; launched Cardiovascular disease (CVD) and Solis division in 2016. Later, the production at Ahmedabad Plant commissioned in Gujarat in 2021. Radiance and Solaris Divisions launched in 2022; followed by Urology division in 2023.

Company is planning an IPO by raising funds of Rs 800 Cr equity shares of Rs 10 each through offer for sale.

Parent organization Indian Private
NSE symbol CORONA
Founded 2004
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Corona Remedies Ltd?

Answer Field

Corona Remedies Ltd share price is for NSE ₹ 1,440.90 & for BSE ₹ 1,440.10 as on Dec 16 2025 02:20 PM.

What is the Market Cap of Corona Remedies Ltd Share?

Answer Field

The market cap of Corona Remedies Ltd for NSE ₹ 8,812.55 & for BSE ₹ 8,807.66 as on Dec 16 2025 02:20 PM.

What is the 52 Week High and Low of Corona Remedies Ltd?

Answer Field

The 52 Week High and Low of Corona Remedies Ltd for NSE is ₹ 1,497.80 and ₹ 1,380.10 and for BSE is ₹ 1,499.00 and ₹ 1,381.05.

What is 1 year return for Corona Remedies Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Corona Remedies Ltd Share?

Answer Field

As on Dec 16 2025 02:20 PM the price-to-earnings (PE) ratio for Corona Remedies Ltd share is 58.97.

What is the PB ratio of Corona Remedies Ltd Share?

Answer Field

As on Dec 16 2025 02:20 PM, the price-to-book (PB) ratio for Corona Remedies Ltd share is 99.03.

How to Buy Corona Remedies Ltd Share?

Answer Field

You can trade in Corona Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Corona Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Corona Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Corona Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59